256 related articles for article (PubMed ID: 14678285)
1. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
[TBL] [Abstract][Full Text] [Related]
2. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
[TBL] [Abstract][Full Text] [Related]
3. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
Attie KM; Julius JR; Stoppani C; Rundle AC
J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
[TBL] [Abstract][Full Text] [Related]
4. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous mutation in the WSXWS equivalaent motif of the growth hormone receptor in a child with poor response to growth hormone therapy.
Tauber MT; Porra V; Dastot F; Molinas C; Amselem S; Cholin S; Rochiccioli P; Bieth E
Growth Horm IGF Res; 1998 Jun; 8(3):211-6. PubMed ID: 10984309
[TBL] [Abstract][Full Text] [Related]
6. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
7. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
[TBL] [Abstract][Full Text] [Related]
8. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
[TBL] [Abstract][Full Text] [Related]
11. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
13. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.
Klammt J; Shen S; Kiess W; Kratzsch J; Stobbe H; Vogel M; Luo F; Pfäffle R
Clin Endocrinol (Oxf); 2015 Mar; 82(3):453-61. PubMed ID: 25196842
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
[TBL] [Abstract][Full Text] [Related]
16. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation of the growth hormone receptor gene (GHR) in a Chinese girl with Laron syndrome.
Chen X; Song F; Dai Y; Bao X; Jin Y
J Pediatr Endocrinol Metab; 2003; 16(8):1183-9. PubMed ID: 14594180
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
19. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
20. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.
Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE
Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
